This web page was created programmatically, to learn the article in its authentic location you may go to the hyperlink bellow:
https://pubmed.ncbi.nlm.nih.gov/40855190/
and if you wish to take away this text from our web site please contact us
doi: 10.1038/s41591-025-03861-x.
Online forward of print.
Affiliations
Item in Clipboard
Nat Med.
.
Abstract
Genetically engineered pig lungs haven’t beforehand been transplanted into people, leaving key questions unanswered concerning the human immune response within the context of a xenotransplanted lung and the opportunity of hyperacute rejection. Here, we report a case of pig-to-human lung xenotransplantation, by which a lung from a six-gene-edited pig was transplanted right into a 39-year-old brain-dead male human recipient following a mind hemorrhage. The lung xenograft maintained viability and performance over the course of the 216 hours of the monitoring interval, with out indicators of hyperacute rejection or an infection. Severe edema resembling main graft dysfunction was noticed at 24 hours after transplantation, probably attributable to ischemia-reperfusion damage. Antibody-mediated rejection appeared to contribute to xenograft injury on postoperative days 3 and 6, with partial restoration by day 9. Immunosuppression included rabbit anti-thymocyte globulin, basiliximab, rituximab, eculizumab, tofacitinib, tacrolimus, mycophenolate mofetil and tapering steroids, with changes made throughout the postoperative interval primarily based on assessments of immune standing. Although this examine demonstrates the feasibility of pig-to-human lung xenotransplantation, substantial challenges regarding organ rejection and an infection stay, and additional preclinical research are essential earlier than medical translation of this process.
© 2025. The Author(s), underneath unique licence to Springer Nature America, Inc.
PubMed Disclaimer
Conflict of curiosity assertion
Competing pursuits: D.P. is a co-founder of Chengdu Clonorgan Biotechnology Co. Ltd, Chengdu, China. The different authors declare competing pursuits.
Similar articles
-
Genetically Modified Porcine Kidneys Have Sufficient Tissue Integrity for Use in Pig-to-Human Xenotransplantation.
Ann Surg. 2024 Sep 1;280(3):374-382. doi: 10.1097/SLA.0000000000006380. Epub 2024 Jun 6.
Ann Surg. 2024.PMID: 38842179
-
Prescription of Controlled Substances: Benefits and Risks.
2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.PMID: 30726003
Free Books & Documents. -
Belatacept for kidney transplant recipients.
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD010699. doi: 10.1002/14651858.CD010699.pub2.
Cochrane Database Syst Rev. 2014.PMID: 25416857
Free PMC article. -
A scientific overview and financial mannequin of the medical and cost-effectiveness of immunosuppressive remedy for renal transplantation in youngsters.
Health Technol Assess. 2006 Dec;10(49):iii-iv, ix-xi, 1-157. doi: 10.3310/hta10490.
Health Technol Assess. 2006.PMID: 17134597
-
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a scientific overview and modelling examine.
Health Technol Assess. 2005 May;9(21):1-179, iii-iv. doi: 10.3310/hta9210.
Health Technol Assess. 2005.PMID: 15899149
References
-
-
Chisholm-Burns, M., Kelly, B. S. & Spivey, C. A. Xenotransplantation might both be a buddy or foe of healthcare fairness. Commun. Med. (Lond.) 4, 85 (2024).
–
PubMed
–
PMC
-
-
-
Mohiuddin, M. M. et al. Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report. Lancet 402, 397–410 (2023).
–
PubMed
–
PMC
-
-
-
Mallapaty, S. & Kozlov, M. First pig kidney transplant in an individual: what it means for the long run. Nature 628, 13–14 (2024).
–
PubMed
-
-
-
Wang, Y. et al. Pig-to-human kidney xenotransplants utilizing genetically modified minipigs. Cell Rep. Med. 5, 101744 (2024).
–
PubMed
–
PMC
-
-
-
Burdorf, L. et al. Pig-to-baboon lung xenotransplantation: prolonged survival with focused genetic modifications and pharmacologic remedies. Am. J. Transplant. 22, 28–45 (2022).
–
PubMed
-
This web page was created programmatically, to learn the article in its authentic location you may go to the hyperlink bellow:
https://pubmed.ncbi.nlm.nih.gov/40855190/
and if you wish to take away this text from our web site please contact us
